Interobserver Reproducibility of MIB-1 Labeling Index in Astrocytic Tumors Using Different Counting Methods

MIB-1 labeling index has been used as a complementary method to differentiate better and worse prognostic groups of astrocytic tumors. However, its reproducibility has been doubted because of the interlaboratory and interobserver variability. We studied the interobserver reproducibility of four manual counting methods of MIB-1 labeling index, including direct counting, area fraction, line intersection with a graticule, and line intersection without a graticule to estimate the total number of the cells. Using line intersection estimate, either with or without a graticule, yielded a worse result. Those MIB-1 labeling indices of astrocytomas were overlapping with those of anaplastic astrocytomas and glioblastomas. Besides, the intraclass correlation coefficient was smaller, and the coefficient of variation was greater than that attained when using a graticule and counting the total number of cells either directly or by area-fraction estimate. The level of interobserver agreement using an MIB-1 labeling index cutoff value of 11.0 was moderate to substantial when applying the line-intersection estimate, and it was almost perfect when applying the direct counting or the area-fraction estimate. The interobserver reproducibility and agreement of MIB-1 labeling index in astrocytic tumors were different depending on the counting methods. Direct counting with a graticule yielded the best result. Before establishing reference standards for staining and counting, the reproducibility of MIB-1 labeling index should be verified.

[1]  B. Everitt,et al.  Statistical methods for rates and proportions , 1973 .

[2]  T. Tihan,et al.  Practical value of Ki-67 and p53 labeling indexes in stereotactic biopsies of diffuse and pilocytic astrocytomas. , 2009, Archives of pathology & laboratory medicine.

[3]  J. R. Landis,et al.  The measurement of observer agreement for categorical data. , 1977, Biometrics.

[4]  A. Berger FUNDAMENTALS OF BIOSTATISTICS , 1969 .

[5]  T. Wong,et al.  MIB‐1 labeling index in nonpilocytic astrocytoma of childhood , 1998, Cancer.

[6]  A. Chiò,et al.  Proliferative activity and prognosis of low-grade astrocytomas , 1997, Journal of Neuro-Oncology.

[7]  T. Seidal,et al.  Interpretation and Quantification of Immunostains , 2001, The American journal of surgical pathology.

[8]  T. Visakorpi,et al.  Prognostication of astrocytoma patient survival by Ki‐67 (MIB‐1), PCNA, and S‐phase fraction using archival paraffin‐embedded samples , 1994, The Journal of pathology.

[9]  K. Gatter,et al.  Ki67 protein: the immaculate deception? , 2002, Histopathology.

[10]  I. Pollack,et al.  Proliferation index as a predictor of prognosis in malignant gliomas of childhood , 1997, Cancer.

[11]  S. Torp,et al.  Comparison of Ki-67 equivalent antibodies. , 2002, Journal of clinical pathology.

[12]  C. Cohen,et al.  Image cytometric measurement of nuclear proliferation markers (MIB-1, PCNA) in astrocytomas. Prognostic significance. , 1998, American journal of clinical pathology.

[13]  T. Montine,et al.  Prognostic significance of Ki-67 proliferation index in supratentorial fibrillary astrocytic neoplasms. , 1994, Neurosurgery.

[14]  B. Nordenskjöld,et al.  Ki-67 antigen expression as a prognostic factor in primary and recurrent astrocytomas. , 1998, Neuro-Chirurgie.

[15]  P. Kleihues,et al.  The Use of the Monoclonal Antibody Ki-67 in the Identification of Proliferating Cells: Application to Surgical Neuropathology , 1986, The American journal of surgical pathology.

[16]  T. Watanabe,et al.  A comparative study of MIB-1 staining indices of gliomas measured by NIH Image analysis program and conventional manual cell counting method , 2000, Neurological research.

[17]  P. Forsyth,et al.  Long-term Glioblastoma Multiforme Survivors: a Population-based Study , 1998, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[18]  M. Greenwood An Introduction to Medical Statistics , 1932, Nature.

[19]  E. Bigio,et al.  Radiation Change Versus Recurrent Astrocytoma: Diagnostic Utility of the Proliferation Index? , 2004, Journal of Neuro-Oncology.

[20]  S. Raab,et al.  Interobserver variability associated with the MIB‐1 labeling index , 2001, Cancer.

[21]  P. Hall,et al.  Detection of the Ki‐67 antigen in fixed and wax‐embedded sections with the monoclonal antibody MIB1 , 1993, Histopathology.

[22]  D G Altman,et al.  Statistics Notes: Measurement error proportional to the mean , 1996, BMJ.

[23]  D. Ross,et al.  A comparison of the predictive power for survival in gliomas provided by MIB-1, bromodeoxyuridine and proliferating cell nuclear antigen with histopathologic and clinical parameters. , 1997, Journal of neuropathology and experimental neurology.

[24]  O. Tawfik,et al.  Comparison of Cyclin A and MIB-1 Expression in Astrocytic Tumors Using Image-Based Cell Analysis System , 2001, Applied immunohistochemistry & molecular morphology : AIMM.

[25]  M Jimbo,et al.  Tumor cell counting using an image analysis program for MIB-1 immunohistochemistry. , 1997, Neurologia medico-chirurgica.